DBV Technologies SA (DBVT)

0.5562 -0.03 (-5.65%) USD  |  NASDAQ  |  May 15, 14:39
More

DBV Technologies Cash and Short Term Investments (Quarterly): 101.52M for March 31, 2024

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2011. Upgrade now.
Date Value
March 31, 2024 101.52M
December 31, 2023 141.37M
September 30, 2023 149.14M
June 30, 2023 173.96M
March 31, 2023 192.29M
December 31, 2022 209.19M
September 30, 2022 212.67M
June 30, 2022 247.97M
March 31, 2022 74.11M
December 31, 2021 77.30M
September 30, 2021 98.20M
June 30, 2021 125.48M
March 31, 2021 152.46M
December 31, 2020 196.35M
June 30, 2020 254.02M
December 31, 2019 193.26M
September 30, 2019 79.88M
June 30, 2019 121.96M
June 30, 2019 121.96M
December 31, 2018 140.44M
Date Value
June 30, 2018 233.84M
June 30, 2018 233.84M
December 31, 2017 165.42M
June 30, 2017 227.28M
June 30, 2017 227.28M
December 31, 2016 269.73M
June 30, 2016 321.20M
June 30, 2016 321.20M
December 31, 2015 353.55M
June 30, 2015 117.25M
June 30, 2015 117.25M
December 31, 2014 139.33M
June 30, 2014 39.65M
June 30, 2014 39.65M
December 31, 2013 54.41M
June 30, 2013 41.98M
June 30, 2013 41.98M
December 31, 2012 50.72M
June 30, 2012 53.40M
December 31, 2011 14.95M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

74.11M
Minimum
Mar 2022
254.02M
Maximum
Jun 2020
153.85M
Average
149.14M
Median
Sep 2023

Cash and Short Term Investments (Quarterly) Benchmarks

Cellectis SA 203.82M
Biophytis SA 6.560M
Edap TMS SA 48.05M
Genfit SA 85.99M
Adaptimmune Therapeutics PLC 146.94M